RxDoctor Payments Data

Katherine Galias, APRN

Adult Health · Crystal Lake, ILNPI 1043230279

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 309 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 42 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,930 and has fallen 88.7% since, to $219 in 2025. Among adult health clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,815in general payments, 2019–2025

Across 309 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$588
  • Boehringer Ingelheim$518
  • Novo Nordisk$480
  • Otsuka America Pharmaceutical, Inc.$470
  • Pfizer$360
  • AbbVie$332
  • plus $3K from 36 others

What the payments were for

  • Food & beverage$5,815100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,815 in reported general payments places this provider in the 90th percentile of 553 adult health providers in Illinois.

See all adult health providers in Illinois

Medicare billing

Part B allowed, 2024
$19,663
Medicare patients
95
Services billed
229

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol31$21,015
Levothyroxine Sodium55$440
Omeprazole30$361
Albuterol Sulfate HfaAlbuterol Sulfate12$299
Metoprolol Succinate27$294
Atorvastatin Calcium37$255
Rosuvastatin Calcium38$247
Tamsulosin Hcl24$221
Losartan Potassium22$158
Escitalopram Oxalate12$128
Metformin Hcl23$122
Lisinopril40$104
Potassium Chloride13$91
Metoprolol Tartrate20$65
Furosemide14$62

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$285$21,01531 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 553 adult health providers in Illinois.

Other adult health in Crystal Lake

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →